Signalling mechanisms regulating phenotypic changes in breast cancer cells

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Epidermal growth factor (EGF) promotes MCF-7 breast cancer cell proliferation.
• Heregulin (HRG)/neuregulin (NRG) induces irreversible phenotypic changes and lipid accumulation in breast cancer cells.
• Signaling mechanisms regulating these cell fate decisions remain poorly understood.

Purpose of the Study:

• To identify molecular mechanisms controlling cell fate decisions in breast cancer cells.
• To investigate the roles of phosphoinositide 3 (PI3) kinase (PI3K), mammalian target of rapamycin (mTOR) complex (mTORC)1, and extracellular-signal-regulated kinase (ERK) pathways.
• To elucidate the impact of signal intensity and duration on cellular responses.

Main Methods:

• Perturbation of signaling pathways activated by growth factors in MCF-7 cells.
• Analysis of lipid accumulation and phenotypic changes.
• Assessment of ATP citrate lyase (ACLY) activation patterns.

Main Results:

• PI3K and mTORC1 activation are essential for lipid accumulation, which can also be induced by insulin.
• Extracellular-signal-regulated kinase (ERK) pathway stimulation is dispensable for lipid accumulation.
• Insulin rapidly triggers lipid accumulation, while HRG requires longer exposure.
• Lipids are produced de novo, indicated by ATP citrate lyase (ACLY) activation.

Conclusions:

• The PI3K pathway regulates phenotypic changes in breast cancer cells.
• Signal intensity and duration are critical determinants of cell fate decisions and commitment.
• MCF-7 cell fate is governed by a regulatory network integrating signaling and metabolic pathways.